Daniel Smrz

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 15

Top Venues

Pharmaceutics

Journal of immunology research

Cancers

International journal of molecular sciences

Charles University, 2nd Faculty of Medicine

Charles University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Charles University, 2nd Faculty of Medicine Jan 01 2013

Czechia

PI :: Institute of Immunology

Education History

Charles University

Czechia

PHD :: Biochemistry

Publications

Katerina Kalkusova, Pavla Taborska, Dmitry Stakheev, Michal Rataj, Sindija Smite, Elea Darras, Julia Albo, Jirina Bartunkova, Luca E Vannucci, Daniel Smrz
Impaired Proliferation of CD8 + T Cells Stimulated with Monocyte-Derived Dendritic Cells Previously Matured with Thapsigargin-Stimulated LAD2 Human Mast Cells. Journal of immunology research 2024 (2024)
Katerina Kalkusova, Pavla Taborska, Dmitry Stakheev, Michal Rataj, Sindija Smite, Elea Darras, Julia Albo, Jirina Bartunkova, Luca E Vannucci, Daniel Smrz
Impaired Proliferation of CD8 + T Cells Stimulated with Monocyte-Derived Dendritic Cells Previously Matured with Thapsigargin-Stimulated LAD2 Human Mast Cells. Journal of immunology research 2024 (2024)
Dmitry Stakheev, Pavla Taborska, Katerina Kalkusova, Jirina Bartunkova, Daniel Smrz
LL-37 as a Powerful Molecular Tool for Boosting the Performance of Ex Vivo-Produced Human Dendritic Cells for Cancer Immunotherapy. Pharmaceutics 14 (12) (2022)
Katerina Kalkusova, Sindija Smite, Elea Darras, Pavla Taborska, Dmitry Stakheev, Luca Vannucci, Jirina Bartunkova, Daniel Smrz
Mast Cells and Dendritic Cells as Cellular Immune Checkpoints in Immunotherapy of Solid Tumors. International journal of molecular sciences 23 (19) (2022)
Dmitry Stakheev, Pavla Taborska, Katerina Kalkusova, Jirina Bartunkova, Daniel Smrz
LL-37 as a Powerful Molecular Tool for Boosting the Performance of Ex Vivo-Produced Human Dendritic Cells for Cancer Immunotherapy. Pharmaceutics 14 (12) (2022)
Dmitry Stakheev, Pavla Taborska, Katerina Kalkusova, Jirina Bartunkova, Daniel Smrz
LL-37 as a Powerful Molecular Tool for Boosting the Performance of Ex Vivo-Produced Human Dendritic Cells for Cancer Immunotherapy. Pharmaceutics 14 (12) (2022)
Katerina Kalkusova, Pavla Taborska, Dmitry Stakheev, Daniel Smrz
The Role of miR-155 in Antitumor Immunity. Cancers 14 (21) (2022)
Zuzana Ozaniak Strizova, Martin Kuchar, Linda Capkova, Martin Komarc, Jiri Skrivan, Jirina Bartunkova, Jan Plzak, Daniel Smrz
Fas-Fas Ligand Interplay in the Periphery of Salivary Gland Carcinomas as a New Checkpoint Predictor for Disease Severity and Immunotherapy Response. Biomedicines 9 (4) (2021)
Pavla Taborska, Jan Lastovicka, Dmitry Stakheev, Zuzana Ozaniak Strizova, Jirina Bartunkova, Daniel Smrz
SARS-CoV-2 spike glycoprotein-reactive T cells can be readily expanded from COVID-19 vaccinated donors. Immunity, inflammation and disease 9 (4) (2021)
Pavla Taborska, Dmitry Stakheev, Jirina Bartunkova, Daniel Smrz
Thapsigargin-Stimulated LAD2 Human Mast Cell Line Is a Potent Cellular Adjuvant for the Maturation of Monocyte-Derived Dendritic Cells for Adoptive Cellular Immunotherapy. International journal of molecular sciences 22 (8) (2021)
Zuzana Ozaniak Strizova, Martin Snajdauf, Dmitry Stakheev, Pavla Taborska, Jiri Vachtenheim, Jan Biskup, Robert Lischke, Jirina Bartunkova, Daniel Smrz
The paratumoral immune cell signature reveals the potential for the implementation of immunotherapy in esophageal carcinoma patients. Journal of cancer research and clinical oncology 146 (8) (2020)
Pavla Taborska, Dmitry Stakheev, Hana Svobodova, Zuzana Strizova, Jirina Bartunkova, Daniel Smrz
Acute Conditioning of Antigen-Expanded CD8+ T Cells via the GSK3β-mTORC Axis Differentially Dictates Their Immediate and Distal Responses after Antigen Rechallenge. Cancers 12 (12) (2020)
Zuzana Ozaniak Strizova, Jirina Bartunkova, Daniel Smrz
The challenges of adoptive cell transfer in the treatment of human renal cell carcinoma. Cancer immunology, immunotherapy : CII 68 (11) (2019)
Dmitry Stakheev, Pavla Taborska, Zuzana Strizova, Michal Podrazil, Jirina Bartunkova, Daniel Smrz
The WNT/β-catenin signaling inhibitor XAV939 enhances the elimination of LNCaP and PC-3 prostate cancer cells by prostate cancer patient lymphocytes in vitro. Scientific reports 9 (1) (2019)
Pavla Taborska, Dmitry Stakheev, Zuzana Strizova, Katerina Vavrova, Michal Podrazil, Jirina Bartunkova, Daniel Smrz
Personalized ex vivo multiple peptide enrichment and detection of T cells reactive to multiple tumor-associated antigens in prostate cancer patients. Medical oncology (Northwood, London, England) 34 (10) (2017)

Daniel Smrz.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Daniel Smrz